Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.54% |
| 2 | Technology | 19.7% |
| 3 | Financials | 7.47% |
| 4 | Consumer Discretionary | 6.7% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4601
Southland Holdings
SLND
$36.5M
| $66.3K | ﹤0.01% |
19,972
+2,092
| +12% | +$8.25K |
2023 Q2
10 quarters
|
|
|
CIRC
4602
Circle8 Group
CIRC
$58.4M
| $66K | ﹤0.01% |
49,635
-10,825
| -18% | -$25.1K |
2025 Q2
2 quarters
|
|
4603
Avita Medical
RCEL
$393M
| $65.8K | ﹤0.01% |
19,075
-556
| -3% | -$2.22K |
2023 Q2
10 quarters
|
|
4604
Lifetime Brands
LCUT
$210M
| $65.7K | ﹤0.01% |
16,629
-25
| -0.2% | -$92 |
2023 Q3
9 quarters
|
|
4605
FT Vest US Equity Buffer ETF June
FJUN
$1.43B
| $65.7K | ﹤0.01% |
+1,151
| New | +$64.9K |
2025 Q4
0 quarters
|
|
|
CNL
4606
Collective Mining Ltd
CNL
$1.12B
| $65.5K | ﹤0.01% |
+4,491
| New | +$54.6K |
2025 Q4
0 quarters
|
|
|
MOMO
4607
Hello Group
MOMO
$678M
| $65.5K | ﹤0.01% |
10,000
+8,745
| +697% | +$60.2K |
2025 Q1
3 quarters
|
|
4608
Global X Artificial Intelligence & Technology ETF
AIQ
$10.5B
| $65.3K | ﹤0.01% |
1,283
-30,438
| -96% | -$1.55M |
2025 Q3
1 quarter
|
|
4609
CarParts.com
PRTS
$66.3M
| $64.6K | ﹤0.01% |
12,925
| – | – |
2022 Q1
15 quarters
|
|
4610
Cardlytics
CDLX
$14.9M
| $64.4K | ﹤0.01% |
5,597
+5,579
| +30,994% | +$86.2K |
2019 Q1
27 quarters
|
|
4611
Innovator US Equity Power Buffer ETF September
PSEP
$1.15B
| $64.3K | ﹤0.01% |
+1,471
| New | +$63.6K |
2025 Q4
0 quarters
|
|
4612
AudioCodes
AUDC
$268M
| $63.7K | ﹤0.01% |
7,294
+7,098
| +3,621% | +$64.6K |
2025 Q2
2 quarters
|
|
4613
Inter&Co
INTR
$2.42B
| $63.4K | ﹤0.01% |
+7,475
| New | +$66.1K |
2025 Q4
0 quarters
|
|
4614
Acumen Pharmaceuticals
ABOS
$148M
| $63.3K | ﹤0.01% |
29,991
| – | – |
2022 Q1
15 quarters
|
|
4615
Clearway Energy Class C
CWEN
$6.02B
| $63K | ﹤0.01% |
1,893
-3,435
| -64% | -$114K |
2013 Q3
49 quarters
|
|
4616
Schneider National
SNDR
$5.77B
| $62.9K | ﹤0.01% |
2,371
+301
| +15% | +$7.11K |
2017 Q2
34 quarters
|
|
4617
Enlight Renewable Energy
ENLT
$9.31B
| $62.9K | ﹤0.01% |
1,383
-4,200
| -75% | -$157K |
2023 Q1
11 quarters
|
|
4618
iShares Global Financials ETF
IXG
$695M
| $62.4K | ﹤0.01% |
+517
| New | +$60.2K |
2025 Q4
0 quarters
|
|
4619
iShares MSCI Switzerland ETF
EWL
$2.67B
| $62.3K | ﹤0.01% |
1,039
+1,015
| +4,229% | +$58.3K |
2013 Q2
50 quarters
|
|
4620
First Guaranty Bancshares
FGBI
$137M
| $61.6K | ﹤0.01% |
11,478
+6,606
| +136% | +$41.5K |
2024 Q3
5 quarters
|
|
4621
Amplify Mobile Payments ETF
IPAY
$146M
| $61.5K | ﹤0.01% |
1,182
| – | – |
2023 Q2
10 quarters
|
|
|
SEPM
4622
FT Vest U.S. Equity Max Buffer ETF - September
SEPM
$32.6M
| $60.8K | ﹤0.01% |
1,912
-2,802
| -59% | -$88.5K |
2024 Q4
4 quarters
|
|
4623
Innovator US Equity Accelerated Plus ETF January
XTJA
$20.3M
| $60.6K | ﹤0.01% |
1,916
-2,892
| -60% | -$90.2K |
2024 Q3
5 quarters
|
|
4624
Open Text
OTEX
$5.38B
| $60.4K | ﹤0.01% |
1,854
+662
| +56% | +$23.6K |
2013 Q2
50 quarters
|
|
4625
Radware
RDWR
$1.29B
| $60.1K | ﹤0.01% |
2,493
-652
| -21% | -$15.9K |
2014 Q3
45 quarters
|
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $23.5B in Q4 2025, closing 641 positions and reducing 1,714 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, down from 44% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.